PSTV

2.25

3.02% -0.07

Dopo l'orario di chiusura: 2.14 -0.11 -4.89%

Plus Therapeutics Inc (PSTV)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.32

Aprire:

$2.22

Volume 24 ore:

40,826

Capitalizzazione di mercato:

$9.80M

Reddito:

Utile/perdita netta:

$-13.32M

Rapporto P/E:

-0.3738

EPS:

-6.02

Flusso di cassa netto:

$-13.01M

1 W Prestazione:

+0.45%

1M Prestazione:

+28.57%

6M Prestazione:

+3.21%

1 anno Prestazione:

-44.58%

Intervallo 1D:

$2.18

$2.30

Portata 52W:

$0.9694

$4.45

Plus Therapeutics Inc Stock (PSTV) Company Profile

Nome

Plus Therapeutics Inc

Settore

Healthcare (1211)

Industria

Biotechnology (697)

Telefono

737 255 7194

Indirizzo

4200 Marathon Boulevard, Suite 200, Austin, TX

Dipendente

Cinguettio

@plustxinc

Prossima data di guadagno

2024-05-13

Ultimi documenti SEC

PSTV's Discussions on Twitter

Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-01-25	Iniziato	Ladenburg Thalmann	Buy
2020-10-16	Iniziato	Maxim Group	Buy

Plus Therapeutics Inc Borsa (PSTV) Ultime notizie

Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress - Investing.com India

Investing.com India

Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress By Investing.com - Investing.com

Investing.com

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

GlobeNewswire

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire Inc.

Plus: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Colorectal Cancer Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies ... - openPR

openPR

Plus Therapeutics Inc Azioni (PSTV) Dati Finanziari